Those who learned they had elevated amyloid levels did not suffer from more short-term anxiety, depression or suicical thoughts, experts reported in JAMA Neurology.
The ACR and MITA both strongly support the proposal to lower screening age and smoking history requirements, but say the recent changes do not go far enough.
Authors of the five-year Project Valuable Area Life-Saving Exams in Town program say their results should prompt the creation of similar strategies across the U.S.
“While the intention of the bill’s sponsors is to protect patients, the unintended consequences of this legislation would increase the risk to patient safety,” said Patrick Hope, executive director of MITA.